Cargando…

[(11)C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates

PURPOSE: Deposition of misfolded alpha-synuclein (αSYN) aggregates in the human brain is one of the major hallmarks of synucleinopathies. However, a target-specific tracer to detect pathological aggregates of αSYN remains lacking. Here, we report the development of a positron emission tomography (PE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuebler, Laura, Buss, Sabrina, Leonov, Andrei, Ryazanov, Sergey, Schmidt, Felix, Maurer, Andreas, Weckbecker, Daniel, Landau, Anne M., Lillethorup, Thea P., Bleher, Daniel, Saw, Ran Sing, Pichler, Bernd J., Griesinger, Christian, Giese, Armin, Herfert, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113290/ https://www.ncbi.nlm.nih.gov/pubmed/33369690 http://dx.doi.org/10.1007/s00259-020-05133-x

Ejemplares similares

(11)C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α‐Synuclein Fibrils in vitro and Crosses the Blood‐Brain Barrier
por: Maurer, Andreas, et al.
Publicado: (2020)

The Structural Combination of SIL and MODAG Scaffolds Fails to Enhance Binding to α-Synuclein but Reveals Promising Affinity to Amyloid β
por: Di Nanni, Adriana, et al.
Publicado: (2023)

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression
por: Bartels, Martin, et al.
Publicado: (2019)

A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [(18)F]PFSB and [(18)F]MFSB
por: Di Nanni, Adriana, et al.
Publicado: (2023)

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
por: Korat, Špela, et al.
Publicado: (2021)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
por: Levin, Johannes, et al.
Publicado: (2022)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
por: Antonschmidt, Leif, et al.
Publicado: (2022)

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
por: Levin, Johannes, et al.
Publicado: (2014)

Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks
por: Marciano, Sabina, et al.
Publicado: (2022)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers
por: Saravanan, Manikam S., et al.
Publicado: (2019)

Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
por: Ruf, Viktoria C., et al.
Publicado: (2020)

Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
por: Wagner, Jens, et al.
Publicado: (2015)

A promising PET tracer candidate targeting α‐synuclein inclusions
por: Xiang, Jie, et al.
Publicado: (2023)

Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
por: Real, Caroline Cristiano, et al.
Publicado: (2023)

[(68)Ga]NOTA-Galactosyl Human Serum Albumin: a Tracer for Liver Function Imaging with Improved Stability
por: Haubner, Roland, et al.
Publicado: (2017)

Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
por: Ozenil, Marius, et al.
Publicado: (2021)

Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations
por: Zizmare, Laimdota, et al.
Publicado: (2022)

Long-Range Distances in Amyloid Fibrils of α-Synuclein from PELDOR Spectroscopy**
por: Pornsuwan, S, et al.
Publicado: (2013)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

NOM 001. Espacio público. Reseña
por: Martí Capitanachi, Daniel Rolando
Publicado: (2023)

The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
por: Smith, Ruben, et al.
Publicado: (2023)

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid‐directed monoclonal antibody
por: gertz, morie a., et al.
Publicado: (2016)

Impact of Strain and Morphology on Magnetic Properties of Fe(3)O(4)/NiO Bilayers Grown on Nb:SrTiO(3)(001) and MgO(001)
por: Kuschel, Olga, et al.
Publicado: (2018)

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
por: Brendel, Matthias, et al.
Publicado: (2019)

Isotopic Tracers
Publicado: (1955)

New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection
por: Wiehr, Stefan, et al.
Publicado: (2016)

Tracer diffusion and PAC measurements of 111mCd tracer atoms in A3B compounds
por: Divinski, Sergiy, et al.
Publicado: (2022)

Application of Isotope Tracer in Cross-Well Nanometre Tracer Testing
por: Pang, Yang, et al.
Publicado: (2022)

Peering into the Brain’s Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders
por: Arjmand, Shokouh, et al.
Publicado: (2023)

Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila
por: Gajula Balija, Madhu Babu, et al.
Publicado: (2011)

The 3D structure of lipidic fibrils of α-synuclein
por: Frieg, Benedikt, et al.
Publicado: (2022)

Multicolor Polymeric Nanoparticle Neuronal Tracers
por: Zang, Nanzhi, et al.
Publicado: (2020)

Retracted: Application of Isotope Tracer in Cross-Well Nanometre Tracer Testing
por: Chemistry, International Journal of Analytical
Publicado: (2023)

The Diffusion of Passive Tracers in Laminar Shear Flow
por: Aminian, Manuchehr, et al.
Publicado: (2018)

Radioactive Tracers in Biology
por: Salter, William T.
Publicado: (1951)

Cannot write session to /tmp/vufind_sessions/sess_2fkjs8dpek3tov5u1c15v0sfn0